Effects of Rosiglitazone on Serum Ghrelin and Peptide YY Levels

We aimed to evaluate the effects of rosiglitazone on serum ghrelin and peptide yy levels in diabetic women.

Completed

Looking for future studies?

Key information

Conditions

Type 2 Diabetes Mellitus Body Weight Diabetes Mellitus Diabetes Mellitus, Type 2 Endocrine System Diseases Glucose Metabolism Disorders Metabolic Diseases Nutrition Disorders Nutritional and Metabolic Diseases Obesity Overnutrition Overweight Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

45 year–65 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 4

Primary location

Baskent University Hospital Department of Endocrinology

Ankara, Bahçelievler, 06490, Turkey (Türkiye)

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

newly diagnosed, drug naive women with type 2 diabetes

Exclusion criteria

presence of severe cardiovascular disease (eg, New York Heart Association class III or IV congestive heart failure or a history of myocardial infarction or stroke)
presence of thyroid, pituitary, nutritional, hepatic, renal, or neoplastic disorders

Treatment and study plan

rosiglitazone

Drug

Sponsors and collaborators

Lead sponsor

Baskent University

Other

Registry information

Official study title

Effects of Rosiglitazone on Serum Ghrelin and Peptide YY Levels in Diabetic Women

Important dates

First posted: Aug 29, 2007
Registry last updated: May 9, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed